Nautilus Biotechnology

Apply to participate in the new Iterative Mapping Grant Program and run 12 of your samples on the Nautilus Voyager™ Platform free of charge! nautilus.bio/iterative-mapp… Terms and conditions apply.

Friday (7/31) is the last day to submit your Iterative Mapping Grant Program application! Through the program, 3 researchers will be selected to join the Iterative Mapping Early Access Program at no charge. Each will receive: 🔵 Analysis of 12 samples with the Nautilus Tau Proteoforms Assay capable of quantifying up to 768 tau proteoforms at the single-molecule level. 🔵 Experimental design support from Nautilus scientists. 🔵 A final data report built for easy interpretation. 🔵 Help presenting results at a mutually agreed-upon conference. 🔵 Assistance preparing a peer-reviewed publication. For more details and to submit your application, visit the Iterative Mapping Grant Program Webpage. Terms and conditions apply. nautilus.bio/iterative-mapp…

On the latest episode of the Translating Proteomics podcast, Nautilus VP of Scientific Engagement and proteomics industry expert Sheri Wilcox joins hosts Parag Mallick and Andreas Huhmer for a thought-provoking discussion of their “proteomics hot takes.” Each “hot take” is a provocative opinion on a topic in proteomics. Specifically, they cover: 🔥 Insufficient biological validation is one of the biggest problems in proteomics (Sheri Wilcox). 🔥 Antibody validation remains a distributed, inconsistent, lab-by-lab responsibility, and this model for validation may not be sustainable going forward (Andreas Huhmer). 🔥 AI cell models are overhyped (Parag Mallick). Check out the episode for deep explorations of each of these hot takes and their potential remedies. nautilus.bio/blog/proteomic… After listening, be sure to let us know whether you agree, disagree, or have your own hot take to share!

New on the Nautilus Blog: An introduction to the Iterative Mapping Grant Program. nautilus.bio/blog/introduci… Submit your project proposals by July 31st, 2026 for a chance to have 12 samples analyzed with the Nautilus Tau Proteoforms Assay at no charge. Brief details of the program: 🔵 3 researchers will be selected 🔵 Each will analyze 12 samples with the Nautilus Tau Proteoforms Assay at no charge 🔵 Each will receive experimental design support from Nautilus scientists 🔵 Each will receive help presenting results at a mutually agreed-upon conference 🔵 Each will receive assistance preparing a peer-reviewed publicaton. More details as well as full terms and conditions can be found on the grant program webpage. nautilus.bio/blog/introduci…

The latest edition of the Nautilus Newsletter is live! Dive in to discover how you can achieve novel insights into functional biology with the Nautilus Voyager™ Platform. nautilus-21430832.hs-sites-na2.com/nautilus-newsl… Topics covered include: 🔵 The Iterative Mapping Grant Program - Run 12 samples on the Nautilus Voyager Platform at no charge. nautilus.bio/iterative-mapp… 🔵 Our latest webinar - Sheri Wilcox walks you through case studies employing the Nautilus Tau Proteoforms Assay, and Amber Faust shares how you can use the assay in your own work. selectscience.net/webinar/how-to… 🔵 The updated Proteomics and neuroscience eBook - Learn more about the tau protein and how researchers are using Iterative Mapping to achieve functional insights into tau's roles in Alzheimer's disease and related dementias. nautilus-21430832.hs-sites-na2.com/download-the-p… 🔵 HUPO 2026 - Set up a meeting with us at HUPO 2026 in Singapore to discuss using the Nautilus Voyager™ Platform in your lab. nautilus-21430832.hs-sites-na2.com/meet-with-naut…

The last day of #AAIC2026 has come too soon! Our time here has already shown us just how critical understanding tau will be to the future of Alzheimer's diagnostics and therapeutics, and we're proud that the Nautilus Voyager™ Platform enables researchers to investigate tau with unprecedented detail. For more information, be sure to drop by booth 220 where you can: 🔵 Learn how the the Nautilus Tau Proteoforms Assay works and vote for new capabilities you'd like to see in future iterations of it 🔵 Discover how you can use the Nautilus Tau Proteoforms Assay at no charge through the Iterative Mapping Grant Program 🔵 Share what other proteins you'd like to study at the proteoform level 🔵 Get your own "MIND THE GAP" t-shirt (see below!) If you don't get a chance to stop by, you can learn all about the Iterative Mapping Grant Program here: nautilus.bio/iterative-mapp… Featured below: Peter Graf, Jamie Rose Kuhar, Ph.D., Amber (Kessinger) Faust, Laurel Goins, and Sheri Wilcox

Today at #AAIC2026, be sure to drop by poster poster 0302 presented by Nicholas Devanney to learn how researchers at the Buck Institute for Research on Aging are using the Nautilus Voyager Platform to explore the tau proteoform landscape of the 3xTg-AD mouse model of Alzheimer's disease. And for additional insights into how researchers are using the Nautilus Tau Proteoforms Assay to reveal tau's role in Alzheimer's disease and related dementias, download the Proteomics and neuroscience eBook: nautilus-21430832.hs-sites-na2.com/download-the-p…

#AAIC2026 is in full swing! Drop by our booth (220) to discover how you can incorporate the Nautilus Voyager™ Platform into your workflows and achieve functional insights through single-molecule proteomics. We're also excited to discuss the new Iterative Mapping Grant Program. Submit an Iterative Mapping project through the form linked below and you may be selected to run 12 of your samples on the Nautilus Voyager Platform at no charge. Terms and conditions apply. nautilus.bio/iterative-mapp…

And apply to participate in the Iterative Mapping Early Access Program free of charge through the Iterative Mapping Grant Program! Terms and conditions apply. nautilus.bio/iterative-mapp…

Check out these posters to learn how researchers are using the Nautilus Voyager™ Platform

#AAIC 2026 is just around the corner! Drop by booth 220 to learn how you can incorporate single-molecule proteomic analysis into your workflows and visit the posters highlighted in the thread below to learn how researchers are already using the Nautilus Voyager™ Platform to explore the impact of tau proteoforms on Alzheimer's disease and related dementias. Set up a meeting with a Nautilus representative at AAIC here: nautilus-21430832.hs-sites-na2.com/meet-with-naut…

Tomorrow at 8am PT, join our webinar to learn how you can achieve mechanistic clarity through accessible single-molecule proteomic analysis on the Nautilus Voyager Platform. Presenters Sheri Wilcox and Amber Faust will cover novel biological insights researchers are already reaching using the Voyager Platform and will further invite you to be one of the first to incorporate the platform into your research. Register here: selectscience.net/webinar/how-to…

#ICYMI, we’ve released the latest edition of the Proteomics and neuroscience eBook! This edition features stories showcasing how researchers at the @BuckInstitute, @NeuralStemCells, @IcahnMountSinai, and the @AllenInstitute are using the Nautilus Voyager™ Platform to explore the mechanisms underlying Alzheimer’s disease and related dementias. Download it here: nautilus-21430832.hs-sites-na2.com/download-the-p… #AlzheimersDisease #Neuroscience #Neurodegeneration #Alzheimers #Proteomics #Proteoforms

This Thursday, July 9th at 8am PT, join Nautilus VP of Scientific Engagement, Sheri Wilcox, Ph.D., and Nautilus VP of Global Sales, Amber (Kessinger) Faust, for a webinar focused on how you can use Iterative Mapping to achieve mechanistic clarity in your studies of biology. The webinar will cover: 🔵 Principles behind Iterative Mapping as an accessible, scalable, and reproducible single-molecule proteomics method. 🔵 How researchers are using Iterative Mapping to explore the roles of tau proteoforms in neurodegenerative diseases. 🔵 How you can be one of the first to use Iterative Mapping in your work. Register here: selectscience.net/webinar/how-to…

📘 The latest edition of the "Proteomics and neuroscience" eBook has arrived! This edition showcases how researchers are using the Nautilus Voyager™ Platform to develop novel insights into the roles of tau proteoforms in Alzheimer’s disease and related dementias. In it, you’ll discover: 🔵 Brief background on the tau protein and its role in Alzheimer’s disease. 🔵 Examples of how researchers are using the Nautilus Voyager Platform to study tau proteoforms at the single-molecule level and develop novel insights into their functional roles in Alzheimer’s disease and related dementias. 🔵 How you can be one of the first to incorporate the Nautilus Voyager Platform into your workflows. Download the eBook here: nautilus-21430832.hs-sites-na2.com/download-the-p…

Register for our upcoming webinar to discover how the Nautilus Voyager™ Platform is beginning to deliver mechanistic clarity in studies of Alzheimer's disease and related dementias. selectscience.net/webinar/how-to… During the webinar, Sheri Wilcox and Amber Faust will also invite you to be one of the first to integrate the Nautilus Voyager™ Platform into your workflows and achieve deep functional insights.

At #AAIC2026, we're excited to share how Iterative Mapping on the Nautilus Voyager™ Platform can accelerate research into tau's mechanistic roles in Alzheimer's disease and related dementias. Check out the posters highlighted below for thorough explorations of tau proteoform data uniquely generated on the Nautilus Voyager Platform. If you'd like to be one of the first to integrate similar single-molecule proteomic analyses into your workflows, be sure to set up a meeting with us or drop by Booth 220 to learn how you can join the Iterative Mapping Early Access Program. Set up a meeting: nautilus-21430832.hs-sites-na2.com/meet-with-naut…

By studying the tau protein at the proteoform level, we firmly believe researchers will discover the mechanisms of neurodegeneration. You can be one of the first to study tau proteoforms with the Nautilus Tau Proteoforms Assay through participation in the Iterative Mapping Early Access Program. In this blog post, we share some of the questions the assay may help answer. If you'd like to answer these or similar questions with the Nautilus Voyager™ Platform, we strongly encourage you to submit your project ideas through the Early Access Program. nautilus.bio/blog/pressing-…

We're excited to attend the Alzheimer's Association International Conference July 12-15 in London, UK. Nautilus representatives will be at the event to discuss: 🔵 How Iterative Mapping is revealing tau's role in neurodegeneration. 🔵 How attendees can use Iterative Mapping to explore the roles of tau proteoforms in Alzheimer's disease. 🔵 Additional proteins attendees wold like to study at the proteoform level. At this year's conference, we're particularly excited to invite attendees to join the Iterative Mapping Early Access Program. By participating in the program, researchers gain exclusive access to the Nautilus Voyager™ Platform and will be among the first to use the platform for targeted proteoform studies and broadscale proteomic analyses. If you'd like to discuss an Early Access Program project or have questions about the Nautilus Voyager™ Platform, please set up a meeting with us at the conference through the link below or reach out through the Early Access Program webpage. Set up a meeting: nautilus-21430832.hs-sites-na2.com/meet-with-naut… Early Access Program webpage: nautilus.bio/nautilusEAP/ #AAIC2026